Effectiveness of Individualised Homoeopathic medicinesin comparison with Berberis Vulgarisin the treatment of Urolithiasis:An open label prospective randomised clinical trial

none0 个研究点目标入组 0 人开始时间: 待定最近更新: 2023年8月21日

试验速览

暂无简介。

•1.Patients diagnosed with urolithiasis (by radiological evidence: Ultrasonography of
•lower abdomen/K.U.B/C.T/M.R.I etc.)
•2.Patients between 20-70 years of age, all religions, all socio-economic status.
•3.All sexes, genders, races.
•4.Patients who are on lifesaving conventional drug therapies (e,g antidiabetics,
•antihypertensives, thyroid drugs)to be continued uninterrupted.
•6.Patients who are willing to give written consent to participate in the study.

•1. Diagnosed cases of unstable mental or psychiatric illness.
•2.Patients who are suffering from any life-threatening illness or other uncontrolled
•systemic disease affecting quality of life or any other vital organ.
•3.Patients who are suffering from any major complication, Congenital Anomalies of
•Kidney and the Urinary Tract, severe hydronephrosis.
•4.Patients who are on active treatment from any other system of medicine.
•5.Patients not willing to give consent for participation in the study.
•6.Patients not willing to undergo any investigation if advised.

发起方

none